Premium
IL ‐23 promotes the development of castration‐resistant prostate cancer
Author(s) -
Yan Juming,
Cua Daniel J,
Teng Michele WL
Publication year - 2018
Publication title -
immunology and cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.999
H-Index - 104
eISSN - 1440-1711
pISSN - 0818-9641
DOI - 10.1111/imcb.12195
Subject(s) - prostate cancer , androgen deprivation therapy , pten , androgen receptor , cancer research , tumor microenvironment , medicine , prostate , castration , cancer , androgen , myeloid derived suppressor cell , immune system , enzalutamide , tramp , immunology , biology , suppressor , apoptosis , pi3k/akt/mtor pathway , hormone , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom